[go: up one dir, main page]

DK168790D0 - - Google Patents

Info

Publication number
DK168790D0
DK168790D0 DK168790A DK168790A DK168790D0 DK 168790 D0 DK168790 D0 DK 168790D0 DK 168790 A DK168790 A DK 168790A DK 168790 A DK168790 A DK 168790A DK 168790 D0 DK168790 D0 DK 168790D0
Authority
DK
Denmark
Prior art keywords
hgh
divalent cation
crystals
derivatives
growth factor
Prior art date
Application number
DK168790A
Other languages
Danish (da)
English (en)
Inventor
Flemming Junker
Claus Friis Theisen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK168790A priority Critical patent/DK168790D0/da
Publication of DK168790D0 publication Critical patent/DK168790D0/da
Priority to NZ238904A priority patent/NZ238904A/xx
Priority to PT98297A priority patent/PT98297B/pt
Priority to ZA915446A priority patent/ZA915446B/xx
Priority to HU9300067A priority patent/HU210323B/hu
Priority to JP3512511A priority patent/JP2524446B2/ja
Priority to DK91913240.7T priority patent/DK0540582T3/da
Priority to HU9300067A priority patent/HUT64086A/hu
Priority to IE244491A priority patent/IE67054B1/en
Priority to AU82846/91A priority patent/AU666465B2/en
Priority to DE69103755T priority patent/DE69103755T2/de
Priority to PCT/DK1991/000203 priority patent/WO1992000998A1/en
Priority to RU93005051/13A priority patent/RU2108341C1/ru
Priority to EP91913240A priority patent/EP0540582B1/en
Priority to ES91913240T priority patent/ES2060399T3/es
Priority to CA002086087A priority patent/CA2086087C/en
Priority to AT91913240T priority patent/ATE110745T1/de
Priority to BG97281A priority patent/BG61267B1/bg
Priority to US08/350,758 priority patent/US5780599A/en
Priority to US09/063,749 priority patent/US6117984A/en
Priority to US09/592,032 priority patent/US6894023B1/en
Priority to US11/130,433 priority patent/US20060116320A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C30B29/58—Macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK168790A 1990-07-13 1990-07-13 DK168790D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
DK168790A DK168790D0 (sv) 1990-07-13 1990-07-13
NZ238904A NZ238904A (en) 1990-07-13 1991-07-10 Cation crystals of growth hormone and derivative; purification and pharmaceutical compositions
PT98297A PT98297B (pt) 1990-07-13 1991-07-11 Processo para a preparacao de cristais cationicos da hormona de crescimento
AT91913240T ATE110745T1 (de) 1990-07-13 1991-07-12 Wachstumshormonkristalle und verfahren zu deren herstellung.
DE69103755T DE69103755T2 (de) 1990-07-13 1991-07-12 Wachstumshormonkristalle und verfahren zu deren herstellung.
RU93005051/13A RU2108341C1 (ru) 1990-07-13 1991-07-12 Способ получения кристаллов гр или производных гр, кристаллы человеческих гр или производных человеческих гр и фармацевтический препарат
JP3512511A JP2524446B2 (ja) 1990-07-13 1991-07-12 成長ホルモン結晶及びこのようなｇｈ―結晶の製造方法
DK91913240.7T DK0540582T3 (da) 1990-07-13 1991-07-12 Væksthormonkrystaller og fremgangsmåde til fremstilling af disse væksthormonkrystaller
HU9300067A HUT64086A (en) 1990-07-13 1991-07-12 Process for producing gh-crystals
IE244491A IE67054B1 (en) 1990-07-13 1991-07-12 Growth hormone crystals and a process for production of these GH-crystals
AU82846/91A AU666465B2 (en) 1990-07-13 1991-07-12 Growth hormone crystals and a process for production of these GH-crystals
ZA915446A ZA915446B (en) 1990-07-13 1991-07-12 Growth hormone crystals and a process for production of these gh-crystals
PCT/DK1991/000203 WO1992000998A1 (en) 1990-07-13 1991-07-12 Growth hormone crystals and a process for production of these gh-crystals
HU9300067A HU210323B (en) 1990-07-13 1991-07-12 Process for producing growth hormone crystals
EP91913240A EP0540582B1 (en) 1990-07-13 1991-07-12 Growth hormone crystals and a process for production of these gh-crystals
ES91913240T ES2060399T3 (es) 1990-07-13 1991-07-12 Cristales de la hormona del crecimiento y procedimiento para la produccion de estos cristales de la hormona del crecimiento.
CA002086087A CA2086087C (en) 1990-07-13 1991-07-12 Growth hormone crystals and a process for production of these gh-crystals
BG97281A BG61267B1 (en) 1990-07-13 1993-01-12 Growth hormone crystals and method for production thereof
US08/350,758 US5780599A (en) 1990-07-13 1994-12-07 Growth hormone crystals and a process for production of growth hormone crystals
US09/063,749 US6117984A (en) 1990-07-13 1998-04-21 Growth hormone crystals and a process for production of these GH-crystals
US09/592,032 US6894023B1 (en) 1990-07-13 2000-06-12 Growth hormone crystals and a process for production of these GH-crystals
US11/130,433 US20060116320A1 (en) 1990-07-13 2005-05-16 Growth hormone crystals and a process for production of these GH-crystals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK168790A DK168790D0 (sv) 1990-07-13 1990-07-13

Publications (1)

Publication Number Publication Date
DK168790D0 true DK168790D0 (sv) 1990-07-13

Family

ID=8107212

Family Applications (2)

Application Number Title Priority Date Filing Date
DK168790A DK168790D0 (sv) 1990-07-13 1990-07-13
DK91913240.7T DK0540582T3 (da) 1990-07-13 1991-07-12 Væksthormonkrystaller og fremgangsmåde til fremstilling af disse væksthormonkrystaller

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91913240.7T DK0540582T3 (da) 1990-07-13 1991-07-12 Væksthormonkrystaller og fremgangsmåde til fremstilling af disse væksthormonkrystaller

Country Status (17)

Country Link
US (1) US6117984A (sv)
EP (1) EP0540582B1 (sv)
JP (1) JP2524446B2 (sv)
AT (1) ATE110745T1 (sv)
AU (1) AU666465B2 (sv)
BG (1) BG61267B1 (sv)
CA (1) CA2086087C (sv)
DE (1) DE69103755T2 (sv)
DK (2) DK168790D0 (sv)
ES (1) ES2060399T3 (sv)
HU (2) HUT64086A (sv)
IE (1) IE67054B1 (sv)
NZ (1) NZ238904A (sv)
PT (1) PT98297B (sv)
RU (1) RU2108341C1 (sv)
WO (1) WO1992000998A1 (sv)
ZA (1) ZA915446B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894023B1 (en) * 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
DK168790D0 (sv) * 1990-07-13 1990-07-13 Novo Nordisk As
CZ283361B6 (cs) * 1991-12-20 1998-03-18 Novo Nordisk A/S Farmaceutický přípravek obsahující růstový hormon a histidin
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
US6197350B1 (en) 1996-12-20 2001-03-06 Takeda Chemical Industries, Ltd. Method of producing a sustained-release preparation
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
JP3723857B2 (ja) * 1998-02-04 2005-12-07 日本ケミカルリサーチ株式会社 ヒト成長ホルモン含有水性医薬組成物
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6451347B1 (en) 1999-03-01 2002-09-17 Alkermes Controlled Therapeutics, Inc. Method for purifying human growth hormone
ES2184716T3 (es) * 1999-06-10 2003-04-16 Max Planck Gesellschaft Encapsulacion de cristales por medio de recubrimientos multicapa.
US6566329B1 (en) 1999-06-28 2003-05-20 Novo Nordisk A/S Freeze-dried preparation of human growth hormone
WO2002011695A2 (en) 2000-08-07 2002-02-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
WO2002028375A1 (en) 2000-10-06 2002-04-11 Jagotec Ag A controlled-release, parenterally administrable microparticle preparation
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
SE517422C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse
SE518007C2 (sv) 2000-11-16 2002-08-13 Bioglan Ab Förfarande för framställning av mikropartiklar
US7105181B2 (en) 2001-10-05 2006-09-12 Jagotec, Ag Microparticles
SE0201599D0 (sv) 2002-03-21 2002-05-30 Skyepharma Ab Microparticles
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
BR0317896A (pt) * 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Complexos de cristais de proteìna e polìmeros iÈnicos
KR20050090430A (ko) 2002-12-31 2005-09-13 알투스 파마슈티컬스 인코포레이티드 인간 성장 호르몬 결정 및 이것의 제조 방법
ZA200505305B (en) * 2002-12-31 2007-07-25 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
WO2005014034A1 (en) * 2003-07-14 2005-02-17 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
JP2009521486A (ja) * 2005-12-23 2009-06-04 アルタス ファーマシューティカルズ インコーポレイテッド ポリカチオン錯化タンパク質結晶を含む組成物およびこれを使用した治療法
JP2010513309A (ja) * 2006-12-18 2010-04-30 アルタス ファーマシューティカルズ インコーポレイテッド ヒト成長ホルモン製剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA653324A (en) * 1962-12-04 G. Brink Norman Growth hormone and methods of preparing the same
US2143590A (en) * 1936-09-26 1939-01-10 Univ Alberta Insulin preparation and process of producing crystals of insulin
US2174862A (en) * 1938-12-30 1939-10-03 Frederick Stearns & Company Process of producing crystalline insulin
US2595278A (en) * 1950-04-28 1952-05-06 Armour & Co Preparation of insulin from pancreas glands
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
US2897117A (en) * 1955-02-10 1959-07-28 Univ Alberta Insulin process
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
EP0343696B1 (en) * 1984-10-04 1996-01-03 Monsanto Company Zinc-associated somatotropins
KR890002631B1 (ko) * 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
IL79681A (en) * 1985-08-12 1991-06-10 Int Minerals & Chem Corp Transition metal complexes of growth hormones and their prolonged release compositions
KR880009044A (ko) * 1987-01-30 1988-09-13 원본미기재 묽은 수용액으로부터 소마토트로핀의 회수방법
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
ES2154627T3 (es) * 1988-08-24 2001-04-16 American Cyanamid Co Estabilizacion de somatotropinas mediante la modificacion de restos de cisteina utilizando mutagenesis de localizacion dirigida o derivatizacion quimica.
US5109117A (en) * 1990-06-26 1992-04-28 Monsanto Company Method of somatotropin naturation using urea and a soluble organic alcohol
DK168790D0 (sv) * 1990-07-13 1990-07-13 Novo Nordisk As
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals

Also Published As

Publication number Publication date
BG97281A (bg) 1994-03-24
DE69103755D1 (de) 1994-10-06
HU9300067D0 (en) 1993-04-28
WO1992000998A1 (en) 1992-01-23
DE69103755T2 (de) 1995-02-23
CA2086087C (en) 1999-09-14
US6117984A (en) 2000-09-12
ZA915446B (en) 1992-03-25
AU8284691A (en) 1992-02-04
RU2108341C1 (ru) 1998-04-10
CA2086087A1 (en) 1992-01-14
JPH05507497A (ja) 1993-10-28
AU666465B2 (en) 1996-02-15
ATE110745T1 (de) 1994-09-15
HUT64086A (en) 1993-11-29
IE912444A1 (en) 1992-01-15
DK0540582T3 (da) 1995-01-30
EP0540582A1 (en) 1993-05-12
PT98297B (pt) 1999-01-29
NZ238904A (en) 1993-04-28
EP0540582B1 (en) 1994-08-31
ES2060399T3 (es) 1994-11-16
BG61267B1 (en) 1997-04-30
HU210323B (en) 1995-03-28
IE67054B1 (en) 1996-02-21
PT98297A (pt) 1992-05-29
JP2524446B2 (ja) 1996-08-14

Similar Documents

Publication Publication Date Title
DK168790D0 (sv)
AU682414B2 (en) Stimulation of growth hormone responsive tissues
AU591774B2 (en) Lysine salt of the gadolinium-dota complex and its applications to diagnosis
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
EP0167856A3 (en) Crystalline calcium pseudomonate and use
AU588072B2 (en) Human preproinsulin-like growth factor i
HU893408D0 (en) Process for the production of glycosamino-glucane salts and medical preparations containing them
NZ228632A (en) Topical otopathic preparations containing ofloxacin
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
GB2190382B (en) "enhanced expression of human interleukin-2 or analogues in mammalian cells.
IL80302A0 (en) Biologically active derivatives of human epsilon-interferon
EP0336368A3 (en) N2-(1-carboxy-3-phenylpropyl)-l-lysine derivative and process of producing lysinopril using the compound
AU624079B2 (en) Novel fluorinated derivatives of amino acids usable more particularly as surfactants or cosurfactants and preparations for biomedical use incorporating these derivatives
ZA891363B (en) Improvements relating to the control of neoplastic tissue growth
EP0257418A3 (en) Oxirane-pseudo-oligosaccharides, process for their synthesis, their use and pharmaceutical preparations
ZA875184B (en) 1,3-propanediamine derivatives,preparation and pharmaceutical composition containing them
AU3406189A (en) Agents for enhancing the growth of livestock
IL77588A0 (en) Agricultural preparations containing bacteria
HU9201483D0 (en) Process for the production of 1h-rh-analogues'acid additive salts, and for the production of medical preparations containing them
AU5349686A (en) Hair growth promoting composition of oxybenzone and padimate-o
PL293000A2 (en) Preparation for intensifying growth of fruit-trees and bacciferous bushes as well as root-stock
CS419188A1 (en) Sulphoalkyllignin's sodium salt and method of its preparation
BG40975A1 (en) Nutritive solution for hydroponous cultivating of carnations
SU1448442A1 (ru) Препарат для лечения и профилактики вольфартиоза сельскохозяйственных животных
AU7185987A (en) Improvements in and relating to the treatment of shellfish

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)